Logo do repositório
 
Publicação

Análise das Serologias para Infeções do Grupo TORCH e do Rastreio para Streptococcus do Grupo B na População de Grávidas de uma Maternidade

dc.contributor.authorLito, David
dc.contributor.authorSalva, Inês
dc.contributor.authorTavares, Maria das Neves
dc.contributor.authorOliveira, Rosa
dc.contributor.authorNeto, Maria Teresa
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblBiblioteca Nacional de Portugal, Centro de Estudos Históricos, CELOM
dc.date.accessioned2017-06-21T22:00:41Z
dc.date.available2017-06-21T22:00:41Z
dc.date.issued2013-09
dc.description.abstractIntroduction: Systematic screening for TORCH infections and group B Streptococcus (GBS) during pregnancy has been an important factor in the improvement of perinatal care. Aim: To evaluate TORCH serology and GBS carriers state in the population of a maternity, to assess variability with age and nationality and to search for congenital infections. Material and Methods: Non-probabilistic prevalence study. Results: 9508 TORCH and 2639 GBS results were registered. Immunity rate for rubella was 93.3\%, higher for Portuguese women; for toxoplasmosis it was 25.7\%, higher among the oldest and foreign women; IgG for CMV was positive in 62.4\%, no influence of age was found. VDRL was reactive in 0.5\%; HBsAg was found to be positive in 2.3\%, higher in foreign women. Antibodies for hepatitis C virus and HIV were found respectively in 1.4\% and 0.7\%. No congenital infections were diagnosed. GBS carrier state was found in 13.9\%. Discussion: A high rate of positive IgG was found for rubella reflecting vaccines policy. For toxoplasmosis the low rate of positives means that a high number of pregnant women have to repeat serology during pregnancy with inherent costs. Like in the general population, a high rate of CMV positive mothers was found. For some infections we found that foreign women had different conditions. Conclusion: Knowledge on TORCH and GBS state helps to better draw guidelines concerning screening policies during pregnancy.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent6
dc.format.extent264927
dc.identifier.issn1646-0758
dc.identifier.otherPURE: 236071
dc.identifier.otherPURE UUID: 1103c579-a6ea-4699-a06c-418f60815190
dc.identifier.otherresearchoutputwizard: 40086
dc.identifier.otherPubMed: 24192094
dc.identifier.otherWOS: 000327481500014
dc.identifier.otherScopus: 84887209825
dc.identifier.otherORCID: /0000-0003-2776-664X/work/67929195
dc.identifier.urihttp://hdl.handle.net/10362/21639
dc.language.isopor
dc.peerreviewedyes
dc.subjectHEPATITIS-C
dc.subjectHerpes Simplex
dc.subjectStreptococcal Infections
dc.subjectHepatitis C
dc.subjectPregnancy Complications, Infectious
dc.subjectCytomegalovirus Infections
dc.subjectRubella
dc.subjectToxoplasmosis
dc.subjectPREGNANT-WOMEN
dc.subjectSDG 3 - Good Health and Well-being
dc.titleAnálise das Serologias para Infeções do Grupo TORCH e do Rastreio para Streptococcus do Grupo B na População de Grávidas de uma Maternidadept
dc.title.alternativeTORCH Serology and Group B Streptococcus Screening Analysis in the Population of a Maternityen
dc.typejournal article
degois.publication.firstPage549
degois.publication.issue5
degois.publication.lastPage554
degois.publication.titleActa Médica Portuguesa
degois.publication.volume26
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
564-7253-1-PB.pdf
Tamanho:
258.72 KB
Formato:
Adobe Portable Document Format